PBIO Insider Trading Activity and SEC Form 4 Filings
PBIO insider trading summary
No open-market insider purchases or sales of Pressure Biosciences Inc (PBIO) have been reported on SEC Form 4 in the past 12 months.
Latest PBIO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 31, 2018 | Bradford Addison Young | Chief Commerical Officer | Buy | $177 (79 @ $2.25) |
| Dec 31, 2018 | Bradford Addison Young | Chief Commerical Officer | Buy | $3K (1,500 @ $2.25) |
| Dec 24, 2018 | Richard T Schumacher | President, CEO | Buy | $200 (100 @ $2.00) |
| Dec 24, 2018 | Richard T Schumacher | President, CEO | Buy | $2K (1,200 @ $1.99) |
| Dec 24, 2018 | Richard T Schumacher | President, CEO | Buy | $428 (200 @ $2.14) |
| Dec 20, 2018 | Richard T Schumacher | President, CEO | Buy | $210 (100 @ $2.10) |
| Dec 20, 2018 | Richard T Schumacher | President, CEO | Buy | $876 (400 @ $2.19) |
| Dec 19, 2018 | Nathan Lawrence | VP of Marketing & Sales | Buy | $2K (1,000 @ $2.00) |
| Dec 18, 2018 | Richard T Schumacher | President, CEO | Buy | $2K (930 @ $2.03) |
| Aug 26, 2014 | Richard T Schumacher | CEO | Buy | $4K (13,200 @ $0.30) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.